Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2019
Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials
S Borchmann, H Müller, I Hude, et al.
Urologia Internationalis
|
January 1, 1997
Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors
R Vorreuther, R Hake, P Borchmann, et al.
Leukemia
|
January 22, 1998
A phase I/II study of idarubicin, dexamethasone and interferon-alpha (I-Dexa) in patients with relapsed or refractory multiple myeloma
K Hübel, H Tesch, B Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma
R Schnell, P Borchmann, J O Staak, et al.
International Journal of Cancer
|
March 17, 2001
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. I. Clinical phase I evaluation
O Manzke, H Tesch, P Borchmann, et al.
Nuklearmedizin. Nuclear Medicine
|
December 6, 2008
[FDG-PET in Hodgkin lymphoma]
C Kobe, M Dietlein, C Mauz-Körholz, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 17, 2008
[Hematology 2008]
P Borchmann, B Eichhorst, M Hellmann, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
May 6, 1998
Effect of IFN-alpha on normal human hematopoiesis: an immunohistochemical and morphometric study on trephine biopsy specimens
J Thiele, C Wickenhauser, C Neuwirth, et al.
Leukemia
|
January 19, 2000
Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin
R Schnell, E Vitetta, J Schindler, et al.
Leukemia & Lymphoma
|
December 30, 1998
DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma
M Reiser, R Schnell, G Straub, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2019
Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials
S Borchmann, H Müller, I Hude, et al.
Urologia Internationalis
|
January 1, 1997
Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors
R Vorreuther, R Hake, P Borchmann, et al.
Leukemia
|
January 22, 1998
A phase I/II study of idarubicin, dexamethasone and interferon-alpha (I-Dexa) in patients with relapsed or refractory multiple myeloma
K Hübel, H Tesch, B Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma
R Schnell, P Borchmann, J O Staak, et al.
International Journal of Cancer
|
March 17, 2001
Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. I. Clinical phase I evaluation
O Manzke, H Tesch, P Borchmann, et al.
Nuklearmedizin. Nuclear Medicine
|
December 6, 2008
[FDG-PET in Hodgkin lymphoma]
C Kobe, M Dietlein, C Mauz-Körholz, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 17, 2008
[Hematology 2008]
P Borchmann, B Eichhorst, M Hellmann, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
May 6, 1998
Effect of IFN-alpha on normal human hematopoiesis: an immunohistochemical and morphometric study on trephine biopsy specimens
J Thiele, C Wickenhauser, C Neuwirth, et al.
Leukemia
|
January 19, 2000
Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin
R Schnell, E Vitetta, J Schindler, et al.
Leukemia & Lymphoma
|
December 30, 1998
DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma
M Reiser, R Schnell, G Straub, et al.
Page
of 5